Molecular Status of Plasma Fibronectin as an Additional Biomarker for Assessment of Alzheimer’s Dementia Risk

Publisher： Karger

E-ISSN： 1421-9824|28|4|338-342

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.28, Iss.4, 2009-10, pp. : 338-342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Prevalence, Assessment and Associations of Falls in Dementia with Lewy Bodies and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 2, 1999-02 ,pp. : 97-103

Karger

Access to resources Recommend Favorite

Early Life Socioeconomic Status and Late Life Risk of Alzheimer’s Disease

By  

Neuroepidemiology, Vol. 25, Iss. 1, 2005-06 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Physiological Falls Risk Assessment in Older People with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 4, 2007-08 ,pp. : 260-265

Karger

Access to resources Recommend Favorite

Diagnostic Accuracy of Mini-Mental Status Examination and Revised Hasegawa Dementia Scale for Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 5-6, 2005-04 ,pp. : 324-330

Karger

Access to resources Recommend Favorite

Galantamine: Additional Benefits to Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 1, 2000-09 ,pp. : 19-27

Karger

Access to resources Recommend Favorite